Ovarian cancer is one of the most serious gynecologic cancers precisely because it is so difficult to catch early. Often called a silent disease, it frequently progresses through early stages without producing symptoms that feel distinctly alarming. By the time many women are diagnosed, the cancer has already spread beyond the ovaries. That reality makes awareness, vigilance, and proactive gynecologic care more important than any single test. At Tidewater Physicians for Women, serving Virginia Beach and Norfolk, we want every patient to understand what ovarian cancer is, who is at risk, and what can be done to improve the odds of earlier detection.
Why Early Detection Matters So Much
The survival statistics for ovarian cancer tell a compelling story about the importance of stage at diagnosis. When ovarian cancer is detected at Stage I, confined to one or both ovaries, the five-year survival rate exceeds 90 percent. By Stage III, when it has spread to the abdominal cavity, that rate drops to around 30 to 40 percent. By Stage IV, it falls further still. The majority of ovarian cancer diagnoses occur at Stage III or beyond, which is why the overall five-year survival rate for all stages combined remains around 50 percent. Shifting even a fraction of diagnoses to earlier stages would save thousands of lives each year.
The challenge is that no reliable routine screening test currently exists for ovarian cancer in women at average risk. Unlike cervical cancer, which has the Pap smear, ovarian cancer does not have an equivalent early detection tool proven effective for the general population. This is precisely why symptom awareness and regular gynecologic care are so critical.
Symptoms to Know and Report
Ovarian cancer does produce symptoms; they are simply easy to attribute to more common, benign conditions. The four symptoms most consistently associated with ovarian cancer are bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, and urinary urgency or frequency. These symptoms are not unusual on their own. What distinguishes an ovarian cancer presentation is their persistence: when these symptoms are new, occur on most days, and last for more than two to three weeks without a clear explanation, they warrant evaluation.
Other symptoms that may occur include back pain, fatigue, changes in bowel habits, and pain during intercourse. Again, none of these is specific to ovarian cancer. The key is not to panic at any one symptom but to pay attention to patterns that are new and persistent, and to bring them to your provider’s attention rather than waiting them out.
Who Is at Higher Risk?
While ovarian cancer can affect any woman, several factors are associated with elevated risk. Understanding your personal risk profile helps inform how proactive your monitoring and conversations with your provider should be.
Family history and genetic mutations: A family history of ovarian, breast, or colorectal cancer on either side of the family raises suspicion for hereditary risk. BRCA1 and BRCA2 gene mutations significantly elevate lifetime ovarian cancer risk, with BRCA1 carrying a 35 to 70 percent lifetime risk and BRCA2 carrying a 10 to 30 percent risk. Lynch syndrome, a hereditary condition affecting DNA repair, also confers substantially elevated risk.
Age: Most ovarian cancers are diagnosed in women over 55, though it can occur at any age. Risk increases steadily with age after menopause.
Reproductive history: Women who have never been pregnant, who experienced infertility, or who reached menopause later in life have modestly elevated risk. Women who have had children, breastfed, or used oral contraceptives for extended periods have lower risk.
Endometriosis: Women with a history of endometriosis have a higher risk of certain types of ovarian cancer, particularly clear cell and endometrioid subtypes.
What Reduces Risk?
Several factors are associated with reduced ovarian cancer risk. Long-term use of oral contraceptives has one of the most consistent protective effects in the research literature, with risk reduction persisting for years after stopping. Pregnancy, breastfeeding, and surgical procedures such as tubal ligation also confer some protection. For women with known BRCA mutations who have completed childbearing, risk-reducing salpingo-oophorectomy can reduce ovarian cancer risk by more than 80 percent and is often recommended at an appropriate age. These decisions deserve careful discussion with a provider through women’s health or gynecology appointments.
The Role of Genetic Counseling
If your family history includes multiple relatives with ovarian, breast, or colorectal cancer, particularly on the same side of the family, or if a relative has a known BRCA or Lynch syndrome mutation, genetic counseling is worth pursuing. Counseling begins with a thorough family history review and helps you understand whether testing is appropriate. A positive result opens the door to enhanced surveillance, risk-reducing interventions, and a more informed conversation about your long-term health strategy.
Staying Engaged With Your Care
Regular gynecologic care remains one of the most important protective measures available. Annual visits provide the opportunity to discuss any new or persistent symptoms, review family history updates, and ensure that any indicated screening or follow-up is addressed. Ultrasound and other evaluations are available when symptoms or risk factors warrant a closer look. If you have concerns about ovarian cancer risk or have experienced persistent symptoms, please do not wait to reach out. Schedule an appointment with Tidewater Physicians for Women in Virginia Beach or Norfolk, or call us at (757) 461-3890.
